Moody’s assigns ‘Aa3’ to Memorial Sloan-Kettering Cancer Center’s bonds

Moody’s Investors Service assigned its “Aa3” rating to New York City-based Memorial Sloan-Kettering Cancer Center’s proposed $304.9 million series 2017-1.

Advertisement

At the same time, Moody’s affirmed the “Aa3” rating on MSKCC’s outstanding bonds, affecting $2.2 billion of debt.

The affirmation and assignment are a result of several factors, including MSKCC’s favorable reputation, robust philanthropy, growing operating revenue, and a large base of total cash and investments. Moody’s also acknowledged the cancer center’s high leverage and heightened capital spending.

The outlook is stable, reflecting Moody’s expectation that MSKCC’s preeminent reputation will help the center expand geographically and sustain strong cash flow margins.

More articles on healthcare finance:
10 grants, donations to healthcare organizations in November
10 recent hospital, health system outlook and credit rating actions
Jackson Health System posts a profit for 6th consecutive year

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.